机构风向标 | 东诚药业(002675)2025年三季度已披露前十大机构持股比例合计下跌3.34个百分点

Group 1 - Dongcheng Pharmaceutical (002675.SZ) released its Q3 2025 report on October 29, 2025, indicating that 8 institutional investors disclosed holdings in the company, totaling 208 million shares, which represents 25.24% of the total share capital [1] - The institutional holding ratio decreased by 3.34 percentage points compared to the previous quarter [1] - Among public funds, only one fund, Xingye Medical Care A, increased its holdings, while two funds, Galaxy Medical Mixed A and Galaxy Kangle Stock A, reduced their holdings [1] Group 2 - From the foreign investment perspective, one foreign fund, Hong Kong Central Clearing Limited, increased its holdings by 0.92% compared to the previous period [2]